Skip to main content
. Author manuscript; available in PMC: 2009 Sep 28.
Published in final edited form as: J Mol Cell Cardiol. 2007 Feb 8;42(4):792–803. doi: 10.1016/j.yjmcc.2007.02.001

Figure-1.

Figure-1

Immunostaining of SkM for hSDF-1α overexpression in vitro after transfection with FuGene™6/phSDF-1α (A) in the absence of 125μM ZnCl2 or (B) in the presence of 125μM ZnCl2. (C) The addition of 125μM ZnCl2 significantly improved the transfection efficiency of FuGene™6, Lipofectamine™2000 and JetPEI™. (D) The highest transfection and expression of SDF-1α in the presence of 125μM ZnCl2 was achieved with FuGene™6 until 7 days of observation.